Atlas Trials

An Open-label, Single Center, Single Participant Study of an Experimental Antisense Oligonucleotide Treatment for TUBB4A-related Leukodystrophy

Clinical trial NCT07222371 · ACTIVE_NOT_RECRUITING

Trial details

NCT number
NCT07222371
Sponsor
University of California, San Diego
Status
ACTIVE_NOT_RECRUITING
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Genetic DiseaseTUBB4A-Related Leukodystrophy
Start date
2025-09-19
Primary completion
2027-09-01
Enrollment
1

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.